A first-in-human Phase I clinical trials of NEO-2734 in cancer
Latest Information Update: 06 Mar 2018
At a glance
- Drugs NEO-2734 (Primary)
- Indications Cancer
- Focus Adverse reactions; First in man
- 06 Mar 2018 New trial record
- 28 Feb 2018 According to a NEOMED media release, company plans to submit an IND application to the U.S. FDA and a CTA application to Health Canada in 2019 and plan to initiate the trial shortly thereafter.